
Work Here?
Work Here?
Work Here?
EKF Diagnostics develops, manufactures, and distributes diagnostic technologies and life-science materials for point-of-care testing, diabetes care, hematology, and biotech applications. Its products include near-patient in-vitro diagnostics devices, glucose monitoring systems, and hematology tools, plus enzymes, reagents, and beta-hydroxybutyrate products for research and pharma production, along with precision fermentation and contract manufacturing services. These products are designed to be used at or near the patient and, in some cases, coupled with data connectivity software to deliver quick, actionable results for clinicians and researchers. EKF aims to improve health outcomes by providing reliable diagnostics and biotech solutions that empower clinicians, scientists, and researchers to make informed decisions.
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Penarth, United Kingdom
Founded
1990
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Paid Sick Leave
Professional Development Budget
Connect with EKF Diagnostics at ADA Scientific Sessions 2026. 26/05/2026. EKF Diagnostics will be attending the American Diabetes Association Scientific Sessions 2026, taking place from 5-8 June 2026 in New Orleans, Louisiana, USA. Visit EKF at booth #927, where its team will be showcasing EKF's comprehensive diabetes care portfolio, designed to support accurate testing, diabetes management, and informed clinical decision-making across a range of healthcare settings, including: * STAT-Site(R) WB - The STAT-Site(R) WB point-of-care system provides rapid and precise quantitative results for β-ketone and glucose measurements from whole blood, ideal for managing and monitoring diabetes patients. * Beta-Hydroxybutyrate LiquiColor(R)- Beta-Hydroxybutyrate LiquiColor(R) reagent is a quantitative, FDA-cleared test for detecting ketones and monitoring diabetic ketoacidosis, compatible with open-channel analyzers, it integrates seamlessly into laboratory workflows. The American Diabetes Association Scientific Sessions 2026 is one of the world's leading diabetes conferences, bringing together clinicians, researchers, healthcare professionals, and industry innovators to explore the latest scientific advances, technologies, and treatment approaches in diabetes care. Don't hesitate to contact your EKF Sales representative or email [email protected] to arrange a dedicated meeting during the event. EKF continues to lead the way with innovative point-of-care diagnostic solutions, enabling rapid, accurate, and accessible testing. Its technologies support informed decision-making, timely interventions, and improved patient outcomes across diabetes care and broader healthcare settings. Stanbio Laboratory, an EKF Diagnostics Company look forward to connecting with you at the ADA Scientific Sessions 2026 and discussing how EKF's diabetes care solutions can support your clinical and diagnostic needs. For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding its Point-of-Care, Life Sciences, or Central Laboratory products and services please visit its contact page.
Connect with EKF Diagnostics at EMS World Live 2026. 21/05/2026. EKF Diagnostics will be attending the EMS World Live 2026, taking place from 27-29 May 2026 at the Austin Marriott Downtown in Austin, Texas. Visit EKF at booth #314, where its team will be showcasing a focused range of point-of-care diagnostic and connectivity solutions designed to support emergency medical services and frontline care, including: * STAT-Site(R) WB: A portable whole blood lactate analyzer, delivering fast and reliable lactate measurements to support rapid clinical assessment in emergency and critical care environments. * DiaSpect(TM) Tm: A hand-held hemoglobin analyzer designed to provide quick, accurate hemoglobin results in both pre-hospital and clinical settings. * EKF Link: EKF's versatile software platform that seamlessly connects point-of-care devices with hospital and laboratory IT systems for streamlined data management and integration. * Field Point: A compact point-of-care collection that includes analyzers, sensor strips, and controls, providing rapid diagnostic and communication tools in demanding healthcare and field-based environments. The EMS World Live 2026 brings together EMS professionals, paramedics, emergency physicians, educators, and healthcare innovators to explore the latest advancements in emergency medicine, patient care, and pre-hospital technologies. Don't hesitate to contact your EKF Sales representative or email [email protected] to arrange a dedicated meeting during the event. EKF continues to lead the way with innovative point-of-care diagnostic solutions, enabling rapid, accurate, and accessible testing. Its technologies support informed decision-making, timely interventions, and improved patient outcomes across emergency, acute, and community healthcare settings. Stanbio Laboratory, an EKF Diagnostics Company look forward to connecting with you at EMS World Live 2026 and discussing how EKF's diagnostic and connectivity solutions can support emergency medical services and frontline healthcare teams. For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding its Point-of-Care, Life Sciences, or Central Laboratory products and services please visit its contact page.
Connect with EKF at AABB 2025 in San Diego, USA. EKF Diagnostics will be exhibiting at the AABB Annual Meeting 2025, taking place 25 - 28 October 2025 at the San Diego Convention Center, San Diego, CA, USA. EKF delivers diagnostic technologies and biotechnology solutions, empowering healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications. EKF Diagnostics is delighted to announce that EKF will be presenting new data at AABB 2025. Join EKF Diagnostics in the Poster Hall (SDCC Exhibit Hall F-H, AABB Learning Theater) to view: In this study, EKF Diagnostics benchmark the DiaSpect Tm hemoglobin analyzer against HemoCue 301, Hemo Control, and ABL90 Flex - all using venous whole blood. The results show excellent agreement, clinically acceptable biases, and underline DiaSpect Tm's key benefits: rapid results, portability, and ease of use. These attributes make it an excellent option for mobile and decentralized donor screening. You can also visit EKF at Booth #1210 to explore its latest diagnostic solutions that support accurate, reliable, and efficient testing. Some of its featured solutions include: * Hemo Control - A hemoglobin and hematocrit analyzer designed to provide quick lab-quality results from one simple test, enhancing patient care in blood banks, hospitals, and medical offices. * DiaSpect Tm - A hand-held hemoglobin analyzer delivering immediate lab-quality results in just one second, making it a valuable tool for screening and testing, essential for remote or mobile settings. * EKF Link - Explore EKF Link, its versatile software platform that connects point-of-care devices seamlessly to hospital and laboratory IT systems. The 2025 AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field. Don't hesitate to contact your EKF Sales representative or email [email protected] to arrange a dedicated meeting. EKF leads the way with cutting-edge point-of-care diagnostic solutions that empower healthcare professionals and patients with rapid, accurate, accessible testing capabilities and results. Its technologies enable informed decision-making, timely interventions, and improved patient outcomes at the point-of-care. EKF Diagnostics look forward to welcoming you to AABB 2025 and exploring how EKF's diagnostic solutions can support your healthcare needs. For specific event enquiries please contact [email protected]. For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding its Point-of-Care, Life Sciences, or Central Laboratory products and services please visit its contact page.
EKF Diagnostics Holdings, the AIM-listed global diagnostics business, has announced the launch of its new Biosen C-Line (Biosen), an advanced version of its industry leading rapid benchtop glucose and lactate analyser.
In October 2022, EKF launched a new version of DiaSpect Tm, now powered by EKF Link, enabling new functions like Hematocrit calculation, quality control management and patient data management functions.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Penarth, United Kingdom
Founded
1990
Find jobs on Simplify and start your career today